Resumen de acción AVTR
Avantor, Inc. se dedica al suministro de productos y servicios de misión crítica a clientes de los sectores biofarmacéutico, sanitario, educativo y gubernamental, tecnologías avanzadas y materiales aplicados en América, Europa, Asia, Oriente Medio y África.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Avantor, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.85 |
| 52 Week High | US$26.16 |
| 52 Week Low | US$16.63 |
| Beta | 1.37 |
| 1 Month Change | -3.94% |
| 3 Month Change | 4.94% |
| 1 Year Change | 21.99% |
| 3 Year Change | -19.48% |
| 5 Year Change | n/a |
| Change since IPO | 71.38% |
Noticias y actualizaciones recientes
Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 32%?
Apr 26
Avantor, Inc.'s (NYSE:AVTR) Popularity With Investors Is Clear
Apr 04Recent updates
Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 32%?
Apr 26Avantor, Inc.'s (NYSE:AVTR) Popularity With Investors Is Clear
Apr 04We Think You Can Look Beyond Avantor's (NYSE:AVTR) Lackluster Earnings
Feb 21Is Avantor (NYSE:AVTR) A Risky Investment?
Feb 11Should You Think About Buying Avantor, Inc. (NYSE:AVTR) Now?
Jan 21Getting In Cheap On Avantor, Inc. (NYSE:AVTR) Might Be Difficult
Dec 31Are Investors Undervaluing Avantor, Inc. (NYSE:AVTR) By 23%?
Dec 09Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor
Dec 01These 4 Measures Indicate That Avantor (NYSE:AVTR) Is Using Debt Extensively
Oct 24Is Now An Opportune Moment To Examine Avantor, Inc. (NYSE:AVTR)?
Oct 03Is There An Opportunity With Avantor, Inc.'s (NYSE:AVTR) 32% Undervaluation?
Sep 10Avantor: Customers Destocking, Order Volumes Down, Challenges To Rating (Rating Downgrade)
Sep 08Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Jul 10Avantor: Promising Long-Term Buy With Potential For Opportunistic Entry
Jun 28At US$19.71, Is Avantor, Inc. (NYSE:AVTR) Worth Looking At Closely?
Jun 22A Look At The Fair Value Of Avantor, Inc. (NYSE:AVTR)
Jun 04Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Apr 17Is Avantor (NYSE:AVTR) A Risky Investment?
Apr 04Why Avantor, Inc. (NYSE:AVTR) Could Be Worth Watching
Mar 22Avantor Non-GAAP EPS of $0.32 beats by $0.02, revenue of $1.8B beats by $10M
Feb 03Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Feb 02Avantor: Re-Rating To Buy, Paying Fair Price At 17x Forward P/E (Rating Upgrade)
Jan 28With EPS Growth And More, Avantor (NYSE:AVTR) Makes An Interesting Case
Jan 09Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Dec 27Is It Time To Consider Buying Avantor, Inc. (NYSE:AVTR)?
Dec 14Avantor: Reduce To Hold, Awaiting Convergence Of Price, Fundamentals
Nov 10Avantor Non-GAAP EPS of $0.34 beats by $0.01, revenue of $1.86B beats by $10M
Oct 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Oct 27Avantor raised to Buy at Citi on valuation disconnect
Oct 05Do Avantor's (NYSE:AVTR) Earnings Warrant Your Attention?
Oct 03We Think Avantor (NYSE:AVTR) Can Stay On Top Of Its Debt
Sep 21Is Avantor, Inc. (NYSE:AVTR) Potentially Undervalued?
Sep 09Avantor Non-GAAP EPS of $0.37 misses by $0.01, revenue of $1.91B misses by $70M
Jul 28Estimating The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Jul 18Avantor, Inc.'s (NYSE:AVTR) P/E Is On The Mark
Jul 05Here's Why Avantor (NYSE:AVTR) Can Manage Its Debt Responsibly
Jun 20Avantor: Narrowing The Relative Valuation Gap
May 20I Ran A Stock Scan For Earnings Growth And Avantor (NYSE:AVTR) Passed With Ease
May 15A Look At The Intrinsic Value Of Avantor, Inc. (NYSE:AVTR)
Apr 08Avantor: Recurrent Revenue And M&A Could Push The Stock Price Up
Mar 03Avantor (NYSE:AVTR) Has A Pretty Healthy Balance Sheet
Feb 04Here's Why We Think Avantor (NYSE:AVTR) Is Well Worth Watching
Jan 20Does This Valuation Of Avantor, Inc. (NYSE:AVTR) Imply Investors Are Overpaying?
Jan 05Avantor Stock: Growth At A Reasonable Price
Dec 16Rentabilidad de los accionistas
| AVTR | US Life Sciences | Mercado US | |
|---|---|---|---|
| 7D | 2.6% | 0.1% | 1.6% |
| 1Y | 22.0% | 2.8% | 25.1% |
Rentabilidad vs. Industria: AVTR superó al sector US Life Sciences , que obtuvo un rendimiento del 1% el año pasado.
Rentabilidad vs. Mercado: AVTR obtuvo unos resultados inferiores a los del mercado US, que fueron del 25.1% el año pasado.
Volatilidad de los precios
| AVTR volatility | |
|---|---|
| AVTR Average Weekly Movement | 4.5% |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: AVTR no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AVTR (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1904 | 14,500 | Michael Stubblefield | www.avantorsciences.com |
Avantor, Inc. se dedica a suministrar productos y servicios de misión crítica a clientes de los sectores biofarmacéutico, sanitario, educativo y gubernamental, tecnologías avanzadas y materiales aplicados en América, Europa, Asia, Oriente Medio y África. La empresa ofrece materiales y consumibles, como productos químicos y reactivos de pureza, productos y suministros de laboratorio, materiales de silicona formulados, excipientes personalizados, conjuntos de un solo uso personalizados, resinas y columnas de cromatografía de procesos, kits de preparación de muestras analíticas, productos de educación y microbiología, kits de ensayos clínicos, bombas peristálticas y puntas de manipulación de fluidos. También suministra equipos y productos de instrumentación, como sistemas de filtración, sistemas de inactivación de virus, incubadoras, instrumentos analíticos, evaporadores, congeladores de temperatura ultrabaja, cabinas de seguridad biológica y suministros para entornos críticos.
Resumen de fundamentos de Avantor, Inc.
| Estadísticas fundamentales de AVTR | |
|---|---|
| Capitalización bursátil | US$16.88b |
| Beneficios(TTM) | US$260.00m |
| Ingresos (TTM) | US$6.87b |
64.9x
Ratio precio-beneficio (PE)2.5x
Ratio precio-ventas (PS)¿Está AVTR sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AVTR | |
|---|---|
| Ingresos | US$6.87b |
| Coste de los ingresos | US$4.56b |
| Beneficio bruto | US$2.31b |
| Otros gastos | US$2.05b |
| Beneficios | US$260.00m |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0.38 |
| Margen bruto | 33.63% |
| Margen de beneficio neto | 3.79% |
| Ratio deuda/patrimonio | 98.5% |
¿Cómo se ha desempeñado AVTR a largo plazo?
Ver rendimiento histórico y comparativa